Primary Job Title Chief Financial Officer Primary Organization 
Cerevast Therapeutics
Location Redmond, Washington, United States Regions Greater Seattle Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Kendall joined Zonar in 2011 and serves as the Company’s Chief Financial Officer. Kendall brings 25 years of financial experience and leadership to Zonar, with a background working with high growth companies.
Previously, Kendall was CFO of Verathon Medical, Inc., a leading designer, developer and manufacturer of proprietary medical devices.
Verathon marketed its products globally with operations in 7 countries and was acquired by Roper Industries in 2009. Kendall was also Corporate Controller for Immunex Corporation, a premier developer of biopharmaceutical technology. He joined Immunex in 1990 and held various financial management positions during the company’s growth from a 200 person research company to a fully integrated research, manufacturing, and sales organization employing more than 2,000 employees with annual sales exceeding $1 billion.
Kendall’s background also includes working with publicly and privately-held companies, as both an executive and consultant, in the areas of corporate compliance, projections and valuations, corporate financing, and accounting operations. He started his career in 1987 as an auditor with the public accounting firm of Deloitte and Touche. He is a CPA and holds a B.A. in business administration from the University of Washington.
